Tumor necrosis factor-alpha in heart failure: More questions than answers

被引：8
作者：
Charakida, M [1 ]
Halcox, JPJ [1 ]
机构：
[1] UCL, Inst Child Hlth, Dept Cardiol, Vasc Physiol Unit, London WC1N 1EH, England
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2005年 / 58卷 / 05期
关键词：
D O I：
10.1157/13074839
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：470 / 472
页数：3
相关论文
共 19 条
  • [1] Serum from patients with severe heart failure downregulates eNOS and is proapoptotic -: Role of tumor necrosis factor-α
    Agnoletti, L
    Curello, S
    Bachetti, T
    Malacarne, F
    Gaia, G
    Comini, L
    Volterrani, M
    Bonetti, P
    Parrinello, G
    Cadei, M
    Grigolato, PG
    Ferrari, R
    [J]. CIRCULATION, 1999, 100 (19) : 1983 - 1991
  • [2] C-reactive protein as a predictor of improvement and readmission in heart failure
    Alonso-Martínez, JL
    Llorente-Diez, B
    Echegaray-Agara, M
    Olaz-Preciado, F
    Urbieta-Echezarreta, M
    González-Arencibia, C
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) : 331 - 336
  • [3] Inflammatory mediators in chronic heart failure: An overview
    Anker, SD
    von Haehling, S
    [J]. HEART, 2004, 90 (04) : 464 - 470
  • [4] How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH
    Anker, SD
    Coats, AJS
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 86 (2-3) : 123 - 130
  • [5] Cytokines as emerging targets in the treatment of heart failure
    Baumgarten, G
    Knuefermann, P
    Mann, DL
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (05) : 216 - 223
  • [6] Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats
    Bozkurt, B
    Kribbs, SB
    Clubb, FJ
    Michael, LH
    Didenko, VV
    Hornsby, PJ
    Seta, Y
    Oral, H
    Spinale, FG
    Mann, DL
    [J]. CIRCULATION, 1998, 97 (14) : 1382 - 1391
  • [7] Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
    Chung, ES
    Packer, M
    Lo, KH
    Fasanmade, AA
    Willerson, JT
    [J]. CIRCULATION, 2003, 107 (25) : 3133 - 3140
  • [8] TRANSCRIPTIONAL REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES - NF-KAPPA-B AND CYTOKINE-INDUCIBLE ENHANCERS
    COLLINS, T
    READ, MA
    NEISH, AS
    WHITLEY, MZ
    THANOS, D
    MANIATIS, T
    [J]. FASEB JOURNAL, 1995, 9 (10) : 899 - 909
  • [9] Endothelium as a therapeutic target in heart failure
    Drexler, H
    [J]. CIRCULATION, 1998, 98 (24) : 2652 - 2655
  • [10] Impaired endothelium-mediated vasodilation in heart failure: Clinical evidence and the potential for therapy
    Elkayam, U
    Khan, S
    Mehboob, A
    Ahsan, N
    [J]. JOURNAL OF CARDIAC FAILURE, 2002, 8 (01) : 15 - 20
12